Klebsiella Pneumoniae Infection Drug Market

List of Tables
Table 1. Klebsiella Pneumoniae Infection Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Klebsiella Pneumoniae Infection Drug Market Trends
Table 3. Klebsiella Pneumoniae Infection Drug Market Drivers
Table 4. Klebsiella Pneumoniae Infection Drug Market Challenges
Table 5. Klebsiella Pneumoniae Infection Drug Market Restraints
Table 6. Global Klebsiella Pneumoniae Infection Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Klebsiella Pneumoniae Infection Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Klebsiella Pneumoniae Infection Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Klebsiella Pneumoniae Infection Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Klebsiella Pneumoniae Infection Drug Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Klebsiella Pneumoniae Infection Drug Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Klebsiella Pneumoniae Infection Drug Revenue Share by Manufacturer, 2017-2022
Table 13. Global Klebsiella Pneumoniae Infection Drug Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Klebsiella Pneumoniae Infection Drug Sales Share by Manufacturer, 2017-2022
Table 15. Global Klebsiella Pneumoniae Infection Drug Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Klebsiella Pneumoniae Infection Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Klebsiella Pneumoniae Infection Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Klebsiella Pneumoniae Infection Drug as of 2021)
Table 18. Top Players of Klebsiella Pneumoniae Infection Drug in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Klebsiella Pneumoniae Infection Drug Product Type
Table 20. Date of International Manufacturers Enter into Klebsiella Pneumoniae Infection Drug Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Klebsiella Pneumoniae Infection Drug Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Klebsiella Pneumoniae Infection Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Klebsiella Pneumoniae Infection Drug Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Klebsiella Pneumoniae Infection Drug Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Klebsiella Pneumoniae Infection Drug Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Klebsiella Pneumoniae Infection Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Klebsiella Pneumoniae Infection Drug Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Klebsiella Pneumoniae Infection Drug Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Klebsiella Pneumoniae Infection Drug Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Klebsiella Pneumoniae Infection Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Klebsiella Pneumoniae Infection Drug Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Klebsiella Pneumoniae Infection Drug Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Klebsiella Pneumoniae Infection Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Acies Bio doo Corporation Information
Table 43. Acies Bio doo Description and Business Overview
Table 44. Acies Bio doo Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Acies Bio doo Klebsiella Pneumoniae Infection Drug Product
Table 46. Acies Bio doo Recent Development
Table 47. Appili Therapeutics Corporation Information
Table 48. Appili Therapeutics Description and Business Overview
Table 49. Appili Therapeutics Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Appili Therapeutics Product
Table 51. Appili Therapeutics Recent Development
Table 52. Debiopharm International SA Corporation Information
Table 53. Debiopharm International SA Description and Business Overview
Table 54. Debiopharm International SA Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Debiopharm International SA Product
Table 56. Debiopharm International SA Recent Development
Table 57. Evaxion Biotech ApS Corporation Information
Table 58. Evaxion Biotech ApS Description and Business Overview
Table 59. Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Evaxion Biotech ApS Product
Table 61. Evaxion Biotech ApS Recent Development
Table 62. F. Hoffmann-La Roche Ltd Corporation Information
Table 63. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 64. F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. F. Hoffmann-La Roche Ltd Product
Table 66. F. Hoffmann-La Roche Ltd Recent Development
Table 67. FOB Synthesis Inc Corporation Information
Table 68. FOB Synthesis Inc Description and Business Overview
Table 69. FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. FOB Synthesis Inc Product
Table 71. FOB Synthesis Inc Recent Development
Table 72. ImmunoClin Corp Corporation Information
Table 73. ImmunoClin Corp Description and Business Overview
Table 74. ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. ImmunoClin Corp Product
Table 76. ImmunoClin Corp Recent Development
Table 77. Innovation Pharmaceuticals Inc Corporation Information
Table 78. Innovation Pharmaceuticals Inc Description and Business Overview
Table 79. Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Innovation Pharmaceuticals Inc Product
Table 81. Innovation Pharmaceuticals Inc Recent Development
Table 82. Kyorin Pharmaceutical Co Ltd Corporation Information
Table 83. Kyorin Pharmaceutical Co Ltd Description and Business Overview
Table 84. Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Kyorin Pharmaceutical Co Ltd Product
Table 86. Kyorin Pharmaceutical Co Ltd Recent Development
Table 87. Melinta Therapeutics Inc Corporation Information
Table 88. Melinta Therapeutics Inc Description and Business Overview
Table 89. Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Melinta Therapeutics Inc Product
Table 91. Melinta Therapeutics Inc Recent Development
Table 92. Nosopharm SAS Corporation Information
Table 93. Nosopharm SAS Description and Business Overview
Table 94. Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Nosopharm SAS Product
Table 96. Nosopharm SAS Recent Development
Table 97. Peptilogics Inc Corporation Information
Table 98. Peptilogics Inc Description and Business Overview
Table 99. Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Peptilogics Inc Product
Table 101. Peptilogics Inc Recent Development
Table 102. Pfizer Inc Corporation Information
Table 103. Pfizer Inc Description and Business Overview
Table 104. Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Pfizer Inc Product
Table 106. Pfizer Inc Recent Development
Table 107. Phico Therapeutics Ltd Corporation Information
Table 108. Phico Therapeutics Ltd Description and Business Overview
Table 109. Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Phico Therapeutics Ltd Product
Table 111. Phico Therapeutics Ltd Recent Development
Table 112. Sarepta Therapeutics Inc Corporation Information
Table 113. Sarepta Therapeutics Inc Description and Business Overview
Table 114. Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Sarepta Therapeutics Inc Product
Table 116. Sarepta Therapeutics Inc Recent Development
Table 117. Shionogi & Co Ltd Corporation Information
Table 118. Shionogi & Co Ltd Description and Business Overview
Table 119. Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Shionogi & Co Ltd Product
Table 121. Shionogi & Co Ltd Recent Development
Table 122. Syntiron LLC Corporation Information
Table 123. Syntiron LLC Description and Business Overview
Table 124. Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Syntiron LLC Product
Table 126. Syntiron LLC Recent Development
Table 127. Tetraphase Pharmaceuticals Inc Corporation Information
Table 128. Tetraphase Pharmaceuticals Inc Description and Business Overview
Table 129. Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Tetraphase Pharmaceuticals Inc Product
Table 131. Tetraphase Pharmaceuticals Inc Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Klebsiella Pneumoniae Infection Drug Customers List
Table 135. Klebsiella Pneumoniae Infection Drug Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Klebsiella Pneumoniae Infection Drug Product Picture
Figure 2. Global Klebsiella Pneumoniae Infection Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Klebsiella Pneumoniae Infection Drug Market Size 2017-2028 (US$ Million)
Figure 4. Global Klebsiella Pneumoniae Infection Drug Sales 2017-2028 (K Pcs)
Figure 5. United States Klebsiella Pneumoniae Infection Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Klebsiella Pneumoniae Infection Drug Market Size 2017-2028 (US$ Million)
Figure 7. United States Klebsiella Pneumoniae Infection Drug Sales 2017-2028 (K Pcs)
Figure 8. United States Klebsiella Pneumoniae Infection Drug Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Klebsiella Pneumoniae Infection Drug Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Klebsiella Pneumoniae Infection Drug Report Years Considered
Figure 11. Product Picture of ATI-1503
Figure 12. Product Picture of CA-824
Figure 13. Product Picture of CC-1807
Figure 14. Product Picture of Cefiderocol
Figure 15. Product Picture of Debio-1454
Figure 16. Product Picture of EBX-004
Figure 17. Product Picture of Others
Figure 18. Global Klebsiella Pneumoniae Infection Drug Market Share by Type in 2022 & 2028
Figure 19. Global Klebsiella Pneumoniae Infection Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 20. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Type (2017-2028)
Figure 21. Global Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2028) & (K Pcs)
Figure 22. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Type (2017-2028)
Figure 23. Global Klebsiella Pneumoniae Infection Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 24. United States Klebsiella Pneumoniae Infection Drug Market Share by Type in 2022 & 2028
Figure 25. United States Klebsiella Pneumoniae Infection Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 26. United States Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Type (2017-2028)
Figure 27. United States Klebsiella Pneumoniae Infection Drug Sales by Type (2017-2028) & (K Pcs)
Figure 28. United States Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Type (2017-2028)
Figure 29. United States Klebsiella Pneumoniae Infection Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 30. Product Picture of Hospital
Figure 31. Product Picture of Clinic
Figure 32. Product Picture of Others
Figure 33. Global Klebsiella Pneumoniae Infection Drug Market Share by Application in 2022 & 2028
Figure 34. Global Klebsiella Pneumoniae Infection Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Application (2017-2028)
Figure 36. Global Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2028) & (K Pcs)
Figure 37. Global Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Application (2017-2028)
Figure 38. Global Klebsiella Pneumoniae Infection Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 39. United States Klebsiella Pneumoniae Infection Drug Market Share by Application in 2022 & 2028
Figure 40. United States Klebsiella Pneumoniae Infection Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 41. United States Klebsiella Pneumoniae Infection Drug Sales Market Share in Value by Application (2017-2028)
Figure 42. United States Klebsiella Pneumoniae Infection Drug Sales by Application (2017-2028) & (K Pcs)
Figure 43. United States Klebsiella Pneumoniae Infection Drug Sales Market Share in Volume by Application (2017-2028)
Figure 44. United States Klebsiella Pneumoniae Infection Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 45. North America Klebsiella Pneumoniae Infection Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 46. North America Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. U.S. Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Canada Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Europe Klebsiella Pneumoniae Infection Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 50. Europe Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 51. Germany Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. France Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.K. Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Italy Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Russia Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 57. Asia-Pacific Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 58. China Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Japan Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. South Korea Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. India Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Australia Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Taiwan Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Indonesia Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Thailand Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Malaysia Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Philippines Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Latin America Klebsiella Pneumoniae Infection Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 69. Latin America Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Mexico Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Brazil Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Argentina Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 74. Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 75. Turkey Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Saudi Arabia Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. UAE Klebsiella Pneumoniae Infection Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Klebsiella Pneumoniae Infection Drug Value Chain
Figure 79. Klebsiella Pneumoniae Infection Drug Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed